About NextGen Exsome
NextGen Exsome is a company founded in 2024. It operates as a B2B. NextGen Exsome offers products and services including Exosome Separation and Purification, Exosome Protein Analysis, Exosome Particle Size Analysis, Exosome Omics Analysis, and Exosome Functional Verification. NextGen Exsome operates in a competitive market with competitors including Accent Microcell and Amster Microcell, among others.
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NextGen Exsome
NextGen Exsome offers a comprehensive portfolio of products and services, including Exosome Separation and Purification, Exosome Protein Analysis, Exosome Particle Size Analysis, Exosome Omics Analysis, and Exosome Functional Verification.
Service for isolating and purifying exosomes from samples.
Integrated technology for profiling exosome proteins.
Detects size, quantity, and purity of exosomes.
Includes genomics, lipidomics, and transcriptomics for exosomes.
Evaluates exosome functionality and pharmacological effects.
Funding Insights of NextGen Exsome
Detailed funding history for NextGen Exsome
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NextGen Exsome
Investment portfolio details for NextGen Exsome
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - NextGen Exsome
Detailed financials for NextGen Exsome
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nextgen Exsome Comparisons
Peer comparison for NextGen Exsome
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NextGen Exsome
NextGen Exsome operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Accent Microcell and Amster Microcell, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Microcrystalline cellulose and excipients are manufactured by Accent Microcell.
|
|
| Locked | Locked | Locked |
Produces excipients like microcrystalline cellulose for pharmaceutical and nutraceutical industries.
|
Detailed competitors of NextGen Exsome
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nextgen Exsome
Complete news archive for NextGen Exsome
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NextGen Exsome
NextGen Exsome was founded in 2024.
NextGen Exsome is a platform focused on the advanced manufacturing of cell and exosome engineering. It delivers services including separation, identification, omics analysis, and functional verification of exosomes. The company supports diverse sectors in medical research and therapy development through precise preparation and traceability technologies. Operating globally, it caters to research institutions and industries requiring raw materials for exosome-based applications.
NextGen Exsome's top competitors include Accent Microcell and Amster Microcell.
NextGen Exsome offers Exosome Separation and Purification, Exosome Protein Analysis, Exosome Particle Size Analysis, Exosome Omics Analysis, and Exosome Functional Verification.